Focus on acute leukemias (Q34747215)

4 August 2017

1 reference

title

Focus on acute leukemias (English)

1 reference

4 August 2017

1 reference

2

Martin S Tallman

1 reference

4 August 2017

D Gary Gilliland

1

1 reference

4 August 2017

publication date

1 June 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

417-420

1 reference

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Molecular genetics of acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900081-8

7 January 2021

10.1016/S1535-6108(02)00081-8

Identifiers

DOI

1 reference

4 August 2017

1 reference